WB
The startup develops genomics and theranostics therapies utilizing liquid and solid biopsy technologies to provide actionable insights for cancer and genetic disease treatment. Their platform enables physicians, biopharmaceutical companies, and researchers to access a reliable database that accelerates drug development and integrates therapeutic approaches into standard patient care.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops genomics and theranostics therapies utilizing liquid and solid biopsy technologies to provide actionable insights for cancer and genetic disease treatment. Their platform enables physicians, biopharmaceutical companies, and researchers to access a reliable database that accelerates drug development and integrates therapeutic approaches into standard patient care.